Laboratório na prática clínica : consulta rápida /

Por Xavier, Ricardo M.

Impact on the Quality of Life of an Educational Program for the Prevention of Work-Related Musculoskeletal Disorders: a randomized controlled trial

Por Santos, Antonio C, Bredemeier, Markus, Rosa, Karen F, Amantéa, Vinicius A, Xavier, Ricardo M
Publicado em 2011

Temporal development of muscle atrophy in murine model of arthritis is related to disease severity

Por Filippin, Lidiane I., Teixeira, Vivian N., Viacava, Paula R., Lora, Priscila S., Xavier, Laura L., Xavier, Ricardo M.
Publicado em 2013

Characterization of joint disease in mucopolysaccharidosis type I mice

Por de Oliveira, Patricia G, Baldo, Guilherme, Mayer, Fabiana Q, Martinelli, Barbara, Meurer, Luise, Giugliani, Roberto, Matte, Ursula, Xavier, Ricardo M
Publicado em 2013

Two-Year Safety and Efficacy Experience in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis Treated with Etanercept and Conventional Disease-Modifying Anti-rheumati...

Por Machado, Daniel A., Guzman, Renato, Xavier, Ricardo M., Simon, Jesus A., Mele, Linda, Shen, Qi, Pedersen, Ronald, Kotak, Sameer, Vlahos, Bonnie
Publicado no Open Rheumatol J (2016)

Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study

Por Huizinga, T W J, Conaghan, Philip G, Martin-Mola, Emilio, Schett, Georg, Amital, Howard, Xavier, Ricardo M, Troum, Orrin, Aassi, Maher, Bernasconi, Corrado, Dougados, Maxime
Publicado no Ann Rheum Dis (2015)

Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study

Por Dougados, Maxime, Kissel, Karsten, Conaghan, Philip G, Mola, Emilio Martin, Schett, Georg, Gerli, Roberto, Hansen, Michael Sejer, Amital, Howard, Xavier, Ricardo M, Troum, Orrin, Bernasconi, Corrado, Huizinga, T W J
Publicado em 2014

Effect of pegylated phosphatidylserine-containing liposomes in experimental chronic arthritis

Por Urbano, Paulo CM, Soccol, Vanete T., Teixeira, Vivian N., Oliveira, Patrícia G., Filippin, Lidiane I., Bonat, Wagner H., de Oliveira, Carolina, Rossi, Gustavo R., Xavier, Ricardo M., Azevedo, Valderilio F.
Publicado no BMC Pharmacol Toxicol (2015)

Serum S100B Levels in Patients with Lupus Erythematosus: Preliminary Observation

Por Portela, Luis V. C., Brenol, João C. T., Walz, Roger, Bianchin, Marino, Tort, Adriano B. L., Canabarro, Ubirajara P., Beheregaray, Simone, Marasca, João A., Xavier, Ricardo M., Neto, Eurico C., Gonçalves, Carlos A., Souza, Diogo O.
Publicado em 2002

The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a...

Por Moots, Robert J., Xavier, Ricardo M., Mok, Chi Chiu, Rahman, Mahboob U., Tsai, Wen-Chan, Al-Maini, Mustafa H., Pavelka, Karel, Mahgoub, Ehab, Kotak, Sameer, Korth-Bradley, Joan, Pedersen, Ron, Mele, Linda, Shen, Qi, Vlahos, Bonnie
Publicado no PLoS One (2017)

Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Res...

Por Moots, Robert J., Xavier, Ricardo M., Mok, Chi Chiu, Rahman, Mahboob U., Tsai, Wen-Chan, Al-Maini, Mustafa H., Pavelka, Karel, Mahgoub, Ehab, Kotak, Sameer, Korth-Bradley, Joan, Pedersen, Ron, Mele, Linda, Shen, Qi, Vlahos, Bonnie
Publicado no PLoS One (2017)

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data

Por De Benedetti, Fabrizio, Brunner, Hermine, Ruperto, Nicola, Cuttica, R, Malattia, Clara, Schneider, Rayfel, Woo, Patricia, Eleftheriou, Despina, Baildam, Eileen, Burgos-Vargas, Ruben, Dolezalova, Pavla, Garay, Stella M, Joos, Rik, Wulffraat, Nico, Zuber, Zbyszek, Zulian, Francesco, Wouters, Carine, Xavier, Ricardo M, Zemel, Lawrence, Wright, Stephen, Kenwright, Andy, Martini, Alberto, Lovell, Daniel
Publicado em 2012

Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial

Por Brunner, Hermine I, Ruperto, Nicolino, Zuber, Zbigniew, Keane, Caroline, Harari, Olivier, Kenwright, Andrew, Lu, Peng, Cuttica, Ruben, Keltsev, Vladimir, Xavier, Ricardo M, Calvo, Inmaculada, Nikishina, Irina, Rubio-Pérez, Nadina, Alexeeva, Ekaterina, Chasnyk, Vyacheslav, Horneff, Gerd, Opoka-Winiarska, Violetta, Quartier, Pierre, Silva, Clovis A, Silverman, Earl, Spindler, Alberto, Baildam, Eileen, Gámir, M Luz, Martin, Alan, Rietschel, Christoph, Siri, Daniel, Smolewska, Elzbieta, Lovell, Daniel, Martini, Alberto, De Benedetti, Fabrizio
Publicado no Ann Rheum Dis (2015)